Northumberland, Tyne and Wear NHS Foundation Trust Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01375920
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cumbria, Northumberland Tyne and Wear NHS Foundation Trust | Jane Barnes | Northumberland, Tyne and Wear NHS Foundation Trust | Northumberland, Tyne and Wear NHS Foundation Trust Northumbe | Northumberland, Tyne and Wear NHS Trust

Active Ingredients

Drugs in Phase 4 Trials (2)

lithium (lithonate) (1 trial)

quetiapine (seroquel) (1 trial)

Drugs in Phase 3 Trials (3)

buprenorphine (1 trial)

methadone (methadose) (1 trial)

metyrapone (metopirone) (1 trial)

Drugs in Phase 2 Trials (1)

levetiracetam (keppra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 4)

Epilepsy (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6